4
Changes in Ownership
CLOROX CO /DE/ Filed Acc 0001225208-18-016433
SVP - Chief Innovation Officer sold 18,366 shares at an average $163.53 ($3,003,433)
- SVP - Chief Innovation Officer acquired 19,510 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-06 | Option exercise | +6,293 | $84.45 | $531,444 | 16,241 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-06 | Option exercise | +5,322 | $72.11 | $383,769 | 21,563 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-06 | Sale | −11,615 | $164.00 | $1,904,893 | 9,948 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Option exercise | +7,080 | $89.82 | $635,926 | 17,028 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Option exercise | +437 | $84.45 | $36,905 | 17,465 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Option exercise | +378 | $72.11 | $27,258 | 17,843 | D |
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Sale | −6,751 | $162.72 | $1,098,541 | 11,092 | D |
| Derivatives | |||||||
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-06 | Option exercise · Stock Option (Right to Buy) | −5,322 | 378 | D | ||
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-06 | Option exercise · Stock Option (Right to Buy) | −6,293 | 437 | D | ||
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Option exercise · Stock Option (Right to Buy) | −378 | 0 | D | ||
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Option exercise · Stock Option (Right to Buy) | −437 | 0 | D | ||
| GARNER DENISE SVP - Chief Innovation Officer | 2018-12-07 | Option exercise · Stock Option (Right to Buy) | −7,080 | 0 | D | ||
| Open-market sales · 18,366 sh · avg $163.53 · $3,003,433 | |||||||
Loading xslF345X03/doc4.xml…